Search filters

List of works by Arianna Draghi

Acquired resistance to cancer immunotherapy

scientific article published on 02 July 2018

Cancer immunotherapy in patients with brain metastases.

scientific article published on 8 March 2018

Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy

scientific article published on 15 August 2022

Data from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses - implications for the management of irAEs

scientific article published on 8 October 2018

Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs

scientific article published on 07 January 2019

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells

scientific article published on 02 July 2019

Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)

scientific article published in February 2023

Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma

scientific article published on 12 November 2020

Rapid Identification of the Tumor-Specific Reactive TIL Repertoire Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens

scientific article published in 2021

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

T cells isolated from patients with checkpoint inhibitor resistant-melanoma are functional and can mediate tumor regression.

scientific article published on 24 April 2018

The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro

scientific article published on 09 November 2020

Transcriptomic signatures of tumors undergoing T cell attack

scientific article published on 17 July 2021

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published in May 2023

Paulina is supported by:

About Paulina

Help